bioMérieux
Hosts World Class Suppliers Summit to Recognize
Outstanding
Suppliers for Dedication and Innovation
DURHAM, N.C. (November 18, 2005) —
bioMérieux, Inc., a world leader in the field
of microbiology diagnostics, recently hosted the 2005
World Class Suppliers Summit to show appreciation for
more than 80 of its largest suppliers.
Click here to read
the press release.
STELLARA™
Demonstrates Significant Cost Savings and Reduction
of
Adverse Drug Events After Only One Year of Implementation
LAS VEGAS, NV (December 5, 2005) — bioMérieux,
Inc. today announced the one-year anniversary for STELLARA™
Clinical Intervention and Patient Monitoring software
launched at last year’s American Society of Health-System
Pharmacists (ASHP) forum in Orlando.
Click
here to read the press release.
bioMérieux
Presents Continuing Education Programs at ASHP
Midyear
Meeting
LAS VEGAS, NV (December 5, 2005) — bioMérieux,
Inc., a leader in the field of microbiology diagnostics,
will host two continuing education programs at the Exhibitor
Theater during the American Society of Health-Systems
Pharmacists (ASHP) 2005 Midyear Meeting to be held at
the Las Vegas Convention Center.
Click here to
read the press release.
bioMérieux
Appoints New Senior Vice President at North American Headquarters
DURHAM, NC (October 26, 2005) — bioMérieux,
Inc., a major player in the field of in vitro diagnostics,
announced the recent appointment of Marta Chase as Senior
Vice President of Quality Assurance and Regulatory Affairs.
Marta will be responsible for developing and implementing
processes and procedures to enhance bioMérieux
quality systems.
Click here to read
the press release.
bioMérieux
Releases Full Capabilities of STELLARA™ Clinical Management System: Étage 4 is Now Available
DURHAM, N.C. (June 30, 2005) — bioMérieux,
Inc. announced the availability of the fourth performance
level (Étage 4) for its STELLARA Clinical Intervention
and Patient Monitoring software. The STELLARA system
provides knowledge-enriched, infectious disease-specific
recommendations to clinicians for medication treatment
management.
Click
here to read the press release.
NucliSens® easyMAG™ — New Innovation from bioMérieux
for Nucleic Acid Extraction
Marcy l'Etoile, France (June 7, 2005) — A world leader
in the field of in vitro diagnostics, bioMérieux
announces the launch of its new automated sample preparation
platform for the extraction of nucleic acid in molecular
diagnostic assays. The NucliSens easyMAG system is the
latest innovation in bioMérieux's range of molecular
diagnostic solutions.
Click
here to read the press release.
bioMérieux
Launches VITEK® 2 Compact for Small to
Mid-sized Labs
DURHAM, N.C. (June 6, 2005) — bioMérieux, Inc.,
today announced the official launch of the VITEK 2 Compact,
an automated bacterial identification and antibiotic
susceptibility testing system (ID/AST). Designed for
small to mid-sized microbiology laboratories, the VITEK
2 Compact recently received U.S. Food and Drug Administration
(FDA) clearance and was introduced today at the 2005
American Society for Microbiology (ASM) General Meeting
in Atlanta, Georgia.
Click
here to read the press release.
Dr.
Joseph Campos, Ph.D., Receives bioMérieux Sonnenwirth
Award for Leadership in Clinical Microbiology
DURHAM, N.C. (June 6, 2005) — The 2005 bioMérieux
Sonnenwirth Award for Leadership in Clinical Microbiology,
proudly sponsored by bioMérieux, Inc., since
1986, honors Joseph M. Campos for leadership in clinical
microbiology. The American Society for Microbiology
(ASM) presented the award in honor of his pioneering
work and service in the area of pediatric clinical microbiology.
Click
here to read the press release.
bioMérieux
Announces FDA Approval of the VITEK® 2
for Testing of SXT Against CA-MRSA
DURHAM, N.C. (June 6, 2005) — bioMérieux, Inc.
recently announced it has received U.S. Food and Drug
Administration (FDA) approval to test Trimethoprim-Sulfamephoxazole
(SXT) on VITEK 2 systems against Staphylococcus
aureus (S. aureus).
Click
here to read the press release.
bioMérieux
demonstrates innovation@work during Annual American
Society
for Microbiology General Meeting
DURHAM, N.C. (June 3, 2005) — bioMérieux,
Inc., a market leader in the field of microbiology diagnostics,
will introduce two new products and host a number of
educational and social events during the 105th American
Society for Microbiology (ASM) General Meeting next
week in Atlanta, Georgia.
Click
here to read the press release.
MDS Diagnostic Services Selects bioMérieux to Fully
Automate Eight Labs
DURHAM, N.C. (May 24, 2005) - bioMérieux,
Inc., a leading medical diagnostics company, today announced
it has secured a five-year contract with MDS Diagnostic
Services, the largest provider of laboratory testing
services in Canada.
Click here
to read the press release.
bioMérieux Launches Innovation in Motion Bus Tour
DURHAM , N.C. ( May 23, 2005 ) — Today, bioMérieux,
Inc., a world leader in the field of in vitro diagnostics, launched its Innovation in Motion tour,
a high-tech bus-board presentation theater and mobile
laboratory.
Click
here to read the press release.
bioMérieux BacT/ALERT® 3D Wins Key
Role in Platelet Collection System
DURHAM, N.C. (April 1, 2005) - bioMérieux, an
international leader in in vitro diagnostics
for medical and industrial applications, today announced
that its BacT/ALERT 3D Microbial Detection System will
play an integral role in a leading Single Donor Platelet
Technology system.
Click
here to read the press release.
bioMérieux
Receives FDA Approval for VITEK® 2 Compact
DURHAM, N.C. (March 15, 2005) - bioMérieux,
Inc. today announced it has received U.S. Food and Drug
Administration (FDA) approval for commercial sales and
marketing of the VITEK 2 Compact, an automated bacterial
identification and antibiotic susceptibility testing
system.
Click
here to read the press release.
bioMérieux Receives Innovation of the Year Award
from Frost & Sullivan
DURHAM, N.C. (February 22, 2005) - bioMérieux,
Inc. today announced it has received the 2004 Product
Innovation of the Year Award for Clinical Diagnostics.
The company, based in France, with North American headquarters
in Durham, North Carolina, was given the award based
on its work in developing and commercializing the VIDAS ® D-Dimer Exclusion assay.
Click
here to read the press release.
View
2004 Press Releases
View 2003 Press Releases
View 2002 Press Releases
View 2001 Press Releases
|
